Fri, April 25, 2025
Thu, April 24, 2025
Wed, April 23, 2025
Tue, April 22, 2025
Mon, April 21, 2025
[ Mon, Apr 21st ] - ZDNet
Fitbit is dying a slow death
Sun, April 20, 2025
Sat, April 19, 2025
Fri, April 18, 2025
Thu, April 17, 2025
Wed, April 16, 2025
Tue, April 15, 2025
Mon, April 14, 2025
Sun, April 13, 2025
Fri, April 11, 2025
Thu, April 10, 2025
Sun, April 6, 2025
[ Sun, Apr 06th ] - Yahoo
health and-fitness
Sat, April 5, 2025
Fri, April 4, 2025
Mon, March 31, 2025

How a New Weight-Loss Pill Could Transform Health


//health-fitness.news-articles.net/content/2025/ .. new-weight-loss-pill-could-transform-health.html
Published in Health and Fitness on by Time   Print publication without navigation

The first truly revolutionary oral drug for obesity, made by Eli Lilly, may soon be on the way.

Eli Lilly's new drug, Zepbound, has been approved by the FDA for chronic weight management in adults with obesity or those who are overweight with at least one weight-related condition, marking a significant advancement in obesity treatment. Zepbound, which is a rebranded version of the diabetes drug Mounjaro, has shown in clinical trials to help patients lose up to 22.5% of their body weight, surpassing the effectiveness of other similar medications like Wegovy. The drug works by mimicking the effects of two gut hormones, GLP-1 and GIP, which help regulate appetite and food intake. Despite its promising results, Zepbound comes with a high cost of about $1,060 per month and potential side effects including nausea, diarrhea, and more severe risks like thyroid tumors in rats. Eli Lilly is also working on an oral version of the drug, aiming to make it more accessible and easier to administer than the current injectable form.

Read the Full Time Article at:
[ https://time.com/7278429/weight-loss-obesity-pill-eli-lilly/ ]

Publication Contributing Sources